Endpoint definition
↥321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
560
Check minimum number of events None
560
Extra metadata
D3_IMMUDEFANTIBODY
No definition available.
321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
560
Check minimum number of events None
560
Extra metadata
List of similar endpoints to Immunodeficiency with predominantly antibody defects based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 553 | 366 | 187 |
Unadjusted prevalence (%) | 0.18 | 0.21 | 0.14 |
Mean age at first event (years) | 45.98 | 45.71 | 46.51 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.06 | 5.04 [1.95, 13.07] | 8.6e-4 | 40 |
15 years | 0.01 | 2.07 [0.75, 5.70] | 1.6e-1 | 14 |
5 years | 0.01 | 6.99 [2.95, 16.59] | 1.0e-5 | 16 |
1 year | - | - | - | - |
Index endpoint: D3_IMMUDEFANTIBODY – Immunodeficiency with predominantly antibody defects
GWS hits: 2
before Immunodeficiency with predominantly antibody defects
after Immunodeficiency with predominantly antibody defects
Loading survival analyses plot
Loading survival analyses table